164 related articles for article (PubMed ID: 26807262)
21. Pseudohypoaldosteronism type 1: management issues.
Sharma R; Pandey M; Kanwal SK; Zennaro MC
Indian Pediatr; 2013 Mar; 50(3):331-3. PubMed ID: 23680607
[TBL] [Abstract][Full Text] [Related]
22. Revealing a subclinical salt-losing phenotype in heterozygous carriers of the novel S562P mutation in the alpha subunit of the epithelial sodium channel.
Riepe FG; van Bemmelen MX; Cachat F; Plendl H; Gautschi I; Krone N; Holterhus PM; Theintz G; Schild L
Clin Endocrinol (Oxf); 2009 Feb; 70(2):252-8. PubMed ID: 18547339
[TBL] [Abstract][Full Text] [Related]
23. Case report: Early molecular confirmation and sodium polystyrene sulfonate management of systemic pseudohypoaldosteronism type I.
Alkhatib EH; Bartlett D; Kanakatti Shankar R; Regier D; Merchant N
Front Endocrinol (Lausanne); 2023; 14():1297335. PubMed ID: 38288475
[TBL] [Abstract][Full Text] [Related]
24. Pseudohypoaldosteronism Type 1: The Presentation and Management of a Neonate With a Novel Mutation of the SCNN1B Gene Found in Two Hispanic Siblings.
Pugh CP
Cureus; 2022 Apr; 14(4):e23918. PubMed ID: 35530903
[TBL] [Abstract][Full Text] [Related]
25. Clinical Management in Systemic Type Pseudohypoaldosteronism Due to
Karacan Küçükali G; Çetinkaya S; Tunç G; Oğuz MM; Çelik N; Akkaş KY; Şenel S; Güleray Lafcı N; Savaş Erdeve Ş
J Clin Res Pediatr Endocrinol; 2021 Nov; 13(4):446-451. PubMed ID: 32840096
[TBL] [Abstract][Full Text] [Related]
26. An infant presenting with failure to thrive and hyperkalaemia owing to transient pseudohypoaldosteronism: case report.
De Clerck M; Vande Walle J; Dhont E; Dehoorne J; Keenswijk W
Paediatr Int Child Health; 2018 Nov; 38(4):277-280. PubMed ID: 28557682
[TBL] [Abstract][Full Text] [Related]
27. Exclusion of serum- and glucocorticoid-induced kinase 1 (SGK1) as a candidate gene for genetically heterogeneous renal pseudohypoaldosteronism type I in eight families.
Riepe FG; Holterhus PM
Am J Nephrol; 2007; 27(2):164-9. PubMed ID: 17317952
[TBL] [Abstract][Full Text] [Related]
28. Erythrocyte Na+,K+-ATPase and nasal potential in pseudohypoaldosteronism.
Bistritzer T; Kerem E; Berkovitch M; Rapoport MJ; Evans S; Aladjem M
Clin Endocrinol (Oxf); 2002 May; 56(5):575-80. PubMed ID: 12030906
[TBL] [Abstract][Full Text] [Related]
29. Clinical and molecular analysis of six Japanese patients with a renal form of pseudohypoaldosteronism type 1.
Hatta Y; Nakamura A; Hara S; Kamijo T; Iwata J; Hamajima T; Abe M; Okada M; Ushio M; Tsuyuki K; Tajima T
Endocr J; 2013; 60(3):299-304. PubMed ID: 23197115
[TBL] [Abstract][Full Text] [Related]
30. A novel nonsense mutation of the mineralocorticoid receptor gene in the renal form of pseudohypoaldosteronism type 1.
Uchida N; Shiohara M; Miyagawa S; Yokota I; Mori T
J Pediatr Endocrinol Metab; 2009 Jan; 22(1):91-5. PubMed ID: 19344080
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel mutation in the human mineralocorticoid receptor gene in a german family with autosomal-dominant pseudohypoaldosteronism type 1: further evidence for marked interindividual clinical heterogeneity.
Riepe FG; Krone N; Morlot M; Ludwig M; Sippell WG; Partsch CJ
J Clin Endocrinol Metab; 2003 Apr; 88(4):1683-6. PubMed ID: 12679457
[TBL] [Abstract][Full Text] [Related]
32. Pseudohypoaldosteronism.
Riepe FG
Endocr Dev; 2013; 24():86-95. PubMed ID: 23392097
[TBL] [Abstract][Full Text] [Related]
33. Pseudohypoaldosteronism Type 1 Newborn Patient with a Novel Mutation in
Seyhanli M; Ilhan O; Gumus E; Bor M; Karaca M
J Pediatr Intensive Care; 2020 Jun; 9(2):145-148. PubMed ID: 32351772
[TBL] [Abstract][Full Text] [Related]
34. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.
Tajima T; Kitagawa H; Yokoya S; Tachibana K; Adachi M; Nakae J; Suwa S; Katoh S; Fujieda K
J Clin Endocrinol Metab; 2000 Dec; 85(12):4690-4. PubMed ID: 11134129
[TBL] [Abstract][Full Text] [Related]
35. Aldosterone resistance: structural and functional considerations and new perspectives.
Zennaro MC; Hubert EL; Fernandes-Rosa FL
Mol Cell Endocrinol; 2012 Mar; 350(2):206-15. PubMed ID: 21664233
[TBL] [Abstract][Full Text] [Related]
36. Pseudohypoaldosteronisms, report on a 10-patient series.
Belot A; Ranchin B; Fichtner C; Pujo L; Rossier BC; Liutkus A; Morlat C; Nicolino M; Zennaro MC; Cochat P
Nephrol Dial Transplant; 2008 May; 23(5):1636-41. PubMed ID: 18424465
[TBL] [Abstract][Full Text] [Related]
37. Pseudohypoaldosteronism type 1 and the genes encoding prostasin, alpha-spectrin, and Nedd4.
Ludwig M; Bidlingmaier F; Reissinger A
Int J Mol Med; 2004 Dec; 14(6):1101-4. PubMed ID: 15547682
[TBL] [Abstract][Full Text] [Related]
38. Systemic Pseudohypoaldosteronism Type 1 Due to a Novel Mutation in SCNN1B Gene: A Case Report.
Joshi K; Verma PK; Barman M
EJIFCC; 2022 Oct; 33(3):268-273. PubMed ID: 36447799
[TBL] [Abstract][Full Text] [Related]
39. Difficulties in the diagnosis and management of eight infants with secondary pseudohypoaldosteronism.
Günay F; Şıklar Z; Berberoğlu M
Turk J Pediatr; 2022; 64(3):490-499. PubMed ID: 35899562
[TBL] [Abstract][Full Text] [Related]
40. A novel mutation of the epithelial Na+ channel causes type 1 pseudohypoaldosteronism.
Bonny O; Knoers N; Monnens L; Rossier BC
Pediatr Nephrol; 2002 Oct; 17(10):804-8. PubMed ID: 12376807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
